Dataset Information


Molecular basis for the unique deubiquitinating activity of the NF-kappaB inhibitor A20.

ABSTRACT: Nuclear factor kappaB (NF-kappaB) activation in tumor necrosis factor, interleukin-1, and Toll-like receptor pathways requires Lys63-linked nondegradative polyubiquitination. A20 is a specific feedback inhibitor of NF-kappaB activation in these pathways that possesses dual ubiquitin-editing functions. While the N-terminal domain of A20 is a deubiquitinating enzyme (DUB) for Lys63-linked polyubiquitinated signaling mediators such as TRAF6 and RIP, its C-terminal domain is a ubiquitin ligase (E3) for Lys48-linked degradative polyubiquitination of the same substrates. To elucidate the molecular basis for the DUB activity of A20, we determined its crystal structure and performed a series of biochemical and cell biological studies. The structure reveals the potential catalytic mechanism of A20, which may be significantly different from papain-like cysteine proteases. Ubiquitin can be docked onto a conserved A20 surface; this interaction exhibits charge complementarity and no steric clash. Surprisingly, A20 does not have specificity for Lys63-linked polyubiquitin chains. Instead, it effectively removes Lys63-linked polyubiquitin chains from TRAF6 without dissembling the chains themselves. Our studies suggest that A20 does not act as a general DUB but has the specificity for particular polyubiquitinated substrates to assure its fidelity in regulating NF-kappaB activation in the tumor necrosis factor, interleukin-1, and Toll-like receptor pathways.


PROVIDER: S-EPMC2346432 | BioStudies | 2008-01-01

REPOSITORIES: biostudies

Similar Datasets

2009-01-01 | S-EPMC2747300 | BioStudies
2009-01-01 | S-EPMC2834951 | BioStudies
2008-01-01 | S-EPMC2423148 | BioStudies
1000-01-01 | S-EPMC2646160 | BioStudies
2004-01-01 | S-EPMC1224040 | BioStudies
2012-01-01 | S-EPMC3463848 | BioStudies
2009-03-24 | GSE15264 | GEO
2010-01-01 | S-EPMC2845278 | BioStudies
2010-05-20 | E-GEOD-15264 | ArrayExpress
2007-01-01 | S-EPMC2203345 | BioStudies